InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,527.20
(
0.61%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.74
(
0.05%
)
Bitcoin
65,717.85
(
1.16%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rwwine

Send PM Follow Ignore
Followers 11
Posts 878
Boards Moderated 0
Alias Born 10/27/2003

rwwine

Re: None

Wednesday, 11/19/2003 9:48:32 AM

Wednesday, November 19, 2003 9:48:32 AM

Post# of 252255
Valuation?

If we consider the true value of squalamine for AMD which DEW has already suggested based on EYET, and then consider other indications (cancers) for which squalamine appears to be a good candidate, then add IL-9 opportunities for respiratory indications, how can a companies like Fortis and Caris project a valuation of only $10/share?

My opinion is $42 within 24 months from today! Anyone else care to project a fair market evaluation 24 months from today?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up